GlassScriptPhysician profile
Stephanie D Aikin
NPI 1699856856
$2,355.30
in general payments reported to CMS, 2019-2025
20 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $138 · 2023: $673 · 2024: $727 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,068.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $778.52 | 2023-2025 | Qelbree, Qelbree |
| Corium, LLC | $406.82 | 2023-2025 | Azstarys |
| Sanofi-Aventis U.S. LLC | $237.43 | 2024-2025 | |
| Pfizer INC. | $155.84 | 2021-2023 | |
| Cumberland Pharmaceuticals, INC. | $141.24 | 2022-2024 | Kristalose |
| Glaxosmithkline, LLC. | $111.96 | 2021-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $90.08 | 2022-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $80.11 | 2023-2025 | |
| Seqirus USA INC | $75.59 | 2024-2025 | Flucelvax |
| Ars Pharmaceuticals Operations, INC. | $46.47 | 2025 | Neffy |
| Insulet Corporation | $42.61 | 2025 | Omnipod |
| Sobi, INC | $35.62 | 2022-2023 | |
| Acadia Pharmaceuticals INC | $34.89 | 2023 | Daybue |
| Ptc Therapeutics, INC. | $23.20 | 2023 | |
| Aytu Biopharma, INC. | $19.74 | 2024 | Karbinal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17.95 | 2023 | |
| Tris Pharma INC | $16.71 | 2025 | Dyanavel Xr |
| Biomerieux INC | $14.40 | 2023 | |
| Impel Pharmaceuticals INC. | $13.61 | 2022 | |
| Pbg Puerto Rico LLC | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Aikin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.